Table 1 The baseline clinicopathological characteristics of NPC patients (n = 225).

From: Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy

Characteristics

Number (%)

Age

 Median

49

 Range

15–71

Sex

 Male

162 (72.0%)

 Female

63 (28.0%)

ECOG PS

 0

133 (59.1%)

 1

89 (39.6%)

 2

3 (1.3%)

T stage

 1

31 (13.8%)

 2

86 (38.2%)

 3

72 (32.0%)

 4

36 (16.0%)

N stage

 0

9 (4.0%)

 1

48 (21.3%)

 2

143 (63.6%)

 3

25 (11.1%)

Clinical stage

 II

34 (15.1%)

 III

132 (58.7%)

 IVa

59 (26.2%)

BMI (kg/m2)

 < 18.5

19 (8.4%)

 18.5–24.0

99 (44.0%)

 > 24.0

107 (47.6%)

 Mean ± SD

23.56 ± 3.38

EBV-DNA (copy/ml)

 < 400

81 (36.0%)

 ≥ 400

61 (27.1%)

 Unknown

83 (36.9%)

Treatment

 CCRT

71 (31.6%)

 Non-CCRT

154 (68.4%)

Relapse

 Yes

19 (8.4%)

 No

206 (91.6%)

Metastasis

 Yes

46 (20.4%)

 No

179 (79.6%)

Death

 Yes

53 (23.6%)

 No

172 (76.4%)

  1. ECOG PS eastern clinical oncology group performance status, BMI body mass index, CCRT concurrent chemoradiation therapy.
Back to article page